Thursday, December 01, 2011

MacroGenics Inks $450M Pharma Deal With Servier - Dec. 01, 2011

BioSpace GenePool
   Thursday, December 01, 2011 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS  |  Subscribe

TOP SPONSOR

Pharm-Olam International Acquires StatWorks, Inc.

With Pharm-Olam's acquisition of StatWorks we have expanded our team Data Management and Biostatistics experts for functional outsourcing and full service clinical trials. Our comprehensive biometric services include:

• Integration of randomization into EDC systems, eliminating IVRS costs, with added benefit of full inventory control over supplies
• Adaptive, Sequential, and Bayesian design methods
• CDISC, SDTM and ADaM datasets
• SAS programming, eCRF design, and medical coding in MedDRA/WHO Drug
• Streamlining and reconciling across SAE, CTMS, and study DB
• Health Outcomes Research and Patient Reported Outcomes
• Protocol development, sample size, and randomization

Contact us for your resource planning atwww.pharm-olam.com, info@pharm-olam.com, USA 1-713-559-7900, UK 44-0-344-891121
Top Stories 
•  MacroGenics Inks $450M Pharma Deal With Servier More...
•  Novartis (NVS) Cutting 183 Workers as Part of Reorganization More...
•  arGEN-X Raises $37 Million in Oversubscribed Series B Round More...
•  Onyx (ONXX) Spurs Pfizer (PFE) Talk With Cancer Drug as Patent Cure More...
•  Biocartis Names Dr. Nayan Gregory Parekh as Chief Executive Officer More...
•  Emerald BioStructures Appoints Johan Pontin as Chairman and CEO More...
•  Ranbaxy Laboratories (RANBAXY.BO)'s Lipitor Copy Threatens Pfizer Inc. (PFE) Sales More...

More Top News
Don't Miss This

Ion AmpliSeq™ Cancer Panel

The new Ion AmpliSeq™ technology for research samples employs a revolutionary workflow for sequencing hundreds of amplicons using as little as 10 ng of FFPE DNA on a $99 sequencing chip. The single-tube assay is as simple as setting up a PCR reaction, and results in superior coverage and sensitive detection of low-allele frequency mutations, all in a single-day workflow.

To find out more about our introductory offer, click here.
Featured Stories
•  Super Athletic Mice Are Fit Because Their Muscles Burn More Sugar, Sanford-Burnham Medical Research Institute Study More...
•  Potent Antibodies Protect Mice From HIV, California Institute of Technology Study More...
•  Compound Defeats Drug-Resistant Bacteria, Brown University Study More...
•  New Anti-HIV Agents More Potent, Less Toxic More...
•  Drug May Dampen Dangerous Side Effect of Stem Cell Transplants, Dana-Farber Cancer Institute Study More...
•  Why Evolutionarily Ancient Brain Areas Are Important, Ruhr-University Study More...
•  Japanese Researchers Turn a Crab Shell Transparent, Kyoto University Study More...
•  New Research Distinguishes Roles of Conscious and Sub-Conscious Awareness in Information Processing, Hebrew University of Jerusalem Study More...
Tower: Facebook
 
More Featured News
Event of the day

Moving from Molecule to Clinical Trial- Overcoming Challenges in the Early Development of Small Molecules. Patheon is proud to bring together four scientific leaders who, in a complimentary half-day seminar, will help you navigate through regulatory obstacles, give you tips for getting your molecule to clinical trials more efficiently, and provide practical case studies that demonstrate how other molecules have successfully moved to clinic. Through this event, you will get the chance to network, meet with scientists, and learn from presentations with solutions to the challenges you currently or might face in the near future. As the global leader in Pharmaceutical Development Services, Patheon is committed to providing effective science-based learning opportunities for local professionals.

Date: Tuesday, December 13, 2011
Time: 8:30am-2:00 pm
Location: Hyatt Regency La Jolla, 3777 La Jolla Village Dr, San Diego, CA 92122 RSVP: events@patheon.com

Please click here for more information.
Latest Market Insight

Next-Generation Protein and Peptide Therapeutics

• Understand the limitations of monoclonal antibodies, how these relate to molecular structure, and which protein alternatives may offer solutions.
• Discover the most innovative delivery technologies that may broaden the applicability of protein therapeutics.
• Gain insight into the crucial issue of immunogenicity; understand the regulatory expectations for testing, and the potential options for minimizing.
• Compare the pros and cons of the next-generation protein therapeutics, and assess which are making progress through the clinic.

Click Here for More Information.


Featured Free Resource

Quantifying the Value of Pipeline Pilot, the Accelrys Scientific Enterprise Platform

This white paper outlines the methodology, sources of value, and quantifiable results from bringing products to market faster, avoiding unproductive experiments, saving developer time, and more.

Request Now!
Top Jobs
Pharm Country (Farmingdale, New York)

Astellas Pharma US
Development Scientist
Assists with the analysis and characterization of discovery nominated compounds, through the early stages of development, to gain regulatory approval for clinical trial initiations.

BioMidwest (Urbana, Illinois)

Carle Foundation Hospital
Vice President of Research & Graduate Medical Education
Responsible for administrative and financial oversight for Carle's Research Institute and its Graduate Medical Education program. This position will function in alliance with the physician leaders over research and graduate medical education.

Biotech Beach (San Diego, California)

Pfizer Inc.
Senior Scientist (CovX)
Primary responsibilities will include guiding and accelerating the optimization of therapeutic peptides as well as designing the enhanced carrier proteins used as conjugation or fusion platforms.

Genetown (Cambridge, Massachusetts)

Vertex
Associate Director, GIS Client Account Management
Responsible for understanding the business, specifically the Global Patient Safety (GPS) function, assist in the prioritization of projects, ensure that projects align with the technology that provides the best possible value to GPS in the context of the overall GIS strategy and influence IT strategy in support of the overall business strategy.

Biotech Bay (Foster City, California)

Life Technologies
Senior Product Applications Specialist
Responsible for providing a broad range of support for product development projects, troubleshooting and pre-sales and post-sales activities for products involved in QA/QC testing in pharmaceutical manufacturing.

Get Noticed! Add your resume to the BioSpace Career Center!
See more than 5,000 job postings in the BioSpace Career Center!
BioSpace Career Fairs

BioSpace Life Science Career Fairs are the biotech industry's premier career events. Featuring well-respected employers from around the nation, our job fairs attract top candidates in the biotech, pharmaceutical, life science and medical device industries.

With such a great number of recruiters and hiring managers from top biotech companies attending our career fairs, there are an abundance of opportunities available for job seekers. Many different disciplines within the industry are represented bringing a diversity of candidates to our job fairs.

Companies seeking pharmaceutical sales representatives and marketing jobs regularly attend our job fairs. Engineering and technical jobs can be found, as well as regulatory jobs and positions in QA/QC. Individuals desiring a science job or a research job will find many opportunities at our job fairs. In addition, hiring managers seeking candidates for clinical research jobs also attend our events.

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
Company of the day

Amylin Ohio LLC
8814 Trade Port Drive
Hamilton, Ohio 45011 U.S.A.

Amylin Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) injection.

More Company Profiles
Free Resources
FREE Subscription to American Laboratory

American Laboratory is a practical resource for analytical chemistry laboratory solutions for chemists and life scientists with interest in the application of modern scientific instrumentation for the practice of analytical/bioanalytical chemistry, basic research, applied spectroscopy, petrochemicals, and material science.
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

BioSpace Inc.
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
BioSpace Inc.
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the BioSpace News Beat Team.

Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong

BioSpace.com - Life. Science. Community.
Legal Notice

• BioSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2011 BioSpace http://www.biospace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here.

Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.



No comments: